Source: PharmaLive

Addison Whitney: Addison Whitney revolutionizes pharmaceutical naming with Ari: the first AI-powered naming platform

Addison Whitney, powered by Syneos Health, a leader in global brand design, proudly announces the launch of Ari, the pharmaceutical industry's first AI-driven naming platform. Designed to address the growing complexities of regulatory and legal naming requirements, Ari represents a transformative leap forward in pharmaceutical brand naming.The post Addison Whitney revolutionizes pharmaceutical naming with Ari: the first AI-powered naming platform appeared first on PharmaLive.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Joe Daley's photo - President of Addison Whitney

President

Joe Daley

CEO Approval Rating

50/100

Read more